Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Chandra Asri Pacific Tbk. (TPIA) Price & Performance

Hetzer Medical Indonesia Tbk.Trade
Chandra Asri Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Hetzer Medical Indonesia Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,880 (market cap 166.97T, 197.42M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 1200.7× Hetzer Medical Indonesia Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (197.42M versus 51.66M). Which is the better fit depends on your goals.

MEDSTPIA
Market Cap
139.06B166.97T
Volume
51.66M197.42M
Lot
516.62K1.97M
Turnover
4.44B373.29B
Average Price
85.971,890.87
Value
4.44B373.29B
Indicative Equilibrium Price
861,880
Indicative Equilibrium Volume
9.62K33.45K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MEDS
View details
TPIA
View details

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS

About Chandra Asri Pacific Tbk.

PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.

Read more on TPIA